Skip to main content

Free Rate of Cardiac or Cerebrovascular Events

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Terumo Medical
Terumo MedicalGermany - Leverkusen
1 program
Transradial Coronary InterventionN/A1 trial
Active Trials
NCT01704911Unknown1,700Est. Mar 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Terumo MedicalTransradial Coronary Intervention

Clinical Trials (1)

Total enrollment: 1,700 patients across 1 trials

NCT01704911Terumo MedicalTransradial Coronary Intervention

Evaluate the Safety And Efficacy of the Transradial Coronary in Comparison With the Transfemoral Coronary Intervention

Start: Oct 2012Est. completion: Mar 20151,700 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.